These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 15743424)

  • 1. New insights into the effect of amorolfine nail lacquer.
    Flagothier C; Piérard-Franchimont C; Piérard GE
    Mycoses; 2005 Mar; 48(2):91-4. PubMed ID: 15743424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy.
    Baran R; Kaoukhov A
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):21-9. PubMed ID: 15649187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement.
    Baran R; Sigurgeirsson B; de Berker D; Kaufmann R; Lecha M; Faergemann J; Kerrouche N; Sidou F
    Br J Dermatol; 2007 Jul; 157(1):149-57. PubMed ID: 17553051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of amorolfine nail lacquer for the prophylaxis of onychomycosis over 3 years.
    Sigurgeirsson B; Olafsson JH; Steinsson JT; Kerrouche N; Sidou F
    J Eur Acad Dermatol Venereol; 2010 Aug; 24(8):910-5. PubMed ID: 20028447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy and safety of amorolfine nail lacquer 5% in onychomycosis, once-weekly versus twice-weekly.
    Reinel D; Clarke C
    Clin Exp Dermatol; 1992 Sep; 17 Suppl 1():44-9. PubMed ID: 1458665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sporicidal effect of amorolfine and other antimycotics used in the therapy of fungal nail infections.
    Seidl HP; Jäckel A; Müller J; Schaller M; Borelli C; Polak A
    Mycoses; 2015 Oct; 58(10):610-9. PubMed ID: 26334024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of 5% amorolfine nail lacquer in Neoscytalidium dimidiatum onychomycosis.
    Bunyaratavej S; Leeyaphan C; Rujitharanawong C; Surawan TM; Muanprasat C; Matthapan L
    J Dermatolog Treat; 2016 Aug; 27(4):359-63. PubMed ID: 26471716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of onychomycosis with oral antifungal agents.
    Iorizzo M; Piraccini BM; Rech G; Tosti A
    Expert Opin Drug Deliv; 2005 May; 2(3):435-40. PubMed ID: 16296765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rationale for combination therapy.
    Evans EG
    Br J Dermatol; 2001 Oct; 145 Suppl 60():9-13. PubMed ID: 11777263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of amorolfine 5% nail lacquer in combination with systemic antifungal agents for onychomycosis: A meta-analysis and systematic review.
    Feng X; Xiong X; Ran Y
    Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28097731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in Spain.
    Lecha M
    Br J Dermatol; 2001 Oct; 145 Suppl 60():21-6. PubMed ID: 11777261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical treatment of onychomycosis with amorolfine 5% nail lacquer: comparative efficacy and tolerability of once and twice weekly use.
    Reinel D
    Dermatology; 1992; 184 Suppl 1():21-4. PubMed ID: 1532336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity.
    Monti D; Saccomani L; Chetoni P; Burgalassi S; Senesi S; Ghelardi E; Mailland F
    Br J Dermatol; 2010 Feb; 162(2):311-7. PubMed ID: 19886884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visualisation of penetration of topical antifungal drug substances through mycosis-infected nails by matrix-assisted laser desorption ionisation mass spectrometry imaging.
    Endringer Pinto F; Bagger C; Kunze G; Joly-Tonetti N; Thénot JP; Osman-Ponchet H; Janfelt C
    Mycoses; 2020 Aug; 63(8):869-875. PubMed ID: 32406142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-reported outcomes from two randomised studies comparing once-weekly application of amorolfine 5% nail lacquer to other methods of topical treatment in distal and lateral subungual onychomycosis.
    Schaller M; Sigurgeirsson B; Sarkany M
    Mycoses; 2017 Dec; 60(12):800-807. PubMed ID: 28925059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of a novel model of onychomycosis in rabbits for evaluation of antifungal agents.
    Shimamura T; Kubota N; Nagasaka S; Suzuki T; Mukai H; Shibuya K
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3150-5. PubMed ID: 21555762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of topical therapies to treat onychomycosis.
    Gupta AK; Ryder JE; Baran R
    Dermatol Clin; 2003 Jul; 21(3):481-9. PubMed ID: 12956200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized comparison of nail surface remanence of three nail lacquers, containing amorolfine 5%, ciclopirox 8% or tioconazole 28%, in healthy volunteers.
    Sidou F; Soto P
    Int J Tissue React; 2004; 26(1-2):17-24. PubMed ID: 15573688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine against Trichophyton rubrum in an in vitro model of dermatophyte nail infection.
    Schaller M; Borelli C; Berger U; Walker B; Schmidt S; Weindl G; Jäckel A
    Med Mycol; 2009 Nov; 47(7):753-8. PubMed ID: 19888808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter, randomized, open-label, controlled study comparing the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution with amorolfine nail lacquer alone in dermatophytic onychomycosis.
    Paul C; Coustou D; Lahfa M; Bulai-Livideanu C; Doss N; Mokthar I; Turki H; Nouira R; Fazaa B; Ben Osman A; Zourabichvili O; Cazeau C; Coubetergues H; Picot S; Bienvenu AL; Voisard JJ
    Dermatology; 2013; 227(2):157-64. PubMed ID: 24051622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.